Introduction
Histamine and serotonin (5-hydroxytryptamine (5-HT)) are biogenic amines with multiple essential functions in vivo and on cultured cells [1] [2] [3] [4] [5] . Both have important roles in acute inflammation and are important neurotransmitters in the central nervous system. Histamine is widely expressed in mammalian tissues by neurons, mast cells and basophils, macrophages, parietal cells of the stomach, many cancer cells, etc.
Histamine's activities are mediated through four G-protein coupled receptors (H1-H4) that exhibit different tissue distributions 6 . H1 is widely distributed, and, in addition to roles in the central nervous system, mediates histamine's roles in immediate hypersensitivity reactions 2, 7 . In these reactions, histamine released from mast cells or basophils has potent effects on vascular smooth muscle cells, causing cell contraction and division, and on vascular endothelial cells (EC), inducing microvascular permeability, and, disputably, EC division. H2 also mediates neurotransmission, but, additionally, gastric acid secretion and T lymphocyte function. H3 serves primarily as a neurotransmitter, whereas the more recently discovered H4 is distributed in cells of hematopoietic lineage and mediates functions such as inflammatory cell chemotaxis, cytokine release, and T lymphocyte activation.
Like histamine, serotonin has multiple functions in the central nervous system and is concentrated peripherally in enterochromaffin cells of the gastrointestinal tract where it has a role in motility 1, 3, 8, 9 . More relevant to the present discussion, serotonin is also found in platelet dense granules, and, along with histamine, in mast cell granules. Upon mast cell or platelet degranulation, serotonin serves as a proinflammatory mediator that increases vascular permeability and is mitogenic for smooth muscle cells and vascular EC [9] [10] [11] . Serotonin also activates monocytes, preventing apoptosis and modulating cytokine and chemokine production. Serotonin's activities are mediated through seven classes of receptors (14 different proteins), as well as independently of receptors through the serotonin transporter, which facilitates reuptake of serotonin in neuronal presynapses 1, 10 .
EC are reported to express several different serotonin receptors including 5-HT1, 5-HT2 and 5-HT-4 12, 13 .
In addition to the multiple and varied functions listed above, there have been claims that histamine and serotonin have roles in angiogenesis. As early as 1969, Zauberman et al 14 reported that both amines induced new blood vessel formation when introduced into the rabbit cornea. A number of papers have implicated histamine in pathological angiogenesis [15] [16] [17] , but mechanistic studies to date have showed this action to be indirect through upregulation of VEGF-A expression 18 . Less is known about a role for serotonin in angiogenesis, though serotonin does affect EC signaling in culture 19 and serotonin deficient (tryptophan hydroxylase 1 null) mice exhibit decreased tumor angiogenesis 8 . Further, Jackson et al 20 reported a role for serotonin in the angiogenesis induced by metastatic carcinoids.
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From VEGF-A is the classic tumor angiogenesis factor but was originally discovered as a potent vascular permeability factor (VPF) 21 . Recent studies have done much to elucidate the steps and mechanisms by which VEGF-A induces angiogenesis and enhances permeability 22 . A number of signaling pathways have been implicated, but most, if not all, begin with activation of VEGF-A receptor 2 (VEGFR-2/KDR/Flk-1) 23 .
Activation of VEGFR-2, in turn, leads to the upregulation of the orphan nuclear receptor and transcription factor TR3 (human)/Nur77 (mouse), and TR3/Nur77 mediates most if not all of VEGF-A's angiogenic and vascular permeabilizing activities 24, 25 . We recently reported that histamine and serotonin also upregulate TR3/Nur77 and that TR3/Nur77 is essential for their vascular permeabilizing activities 25 . This finding was unexpected in that histamine and serotonin act through G-coupled receptors that are unrelated to VEGFR-2.
Together these findings prompted us to investigate whether histamine and serotonin induced angiogenesis and, if so, by what mechanisms. Here, we report that both histamine and serotonin, acting through their specific receptors and independent of VEGF-A and VEGFR-2, induce HUVEC proliferation, migration and tube formation in vitro and angiogenesis in vivo. Moreover, like VEGF-A, these actions are mediated through TR3/Nur77. As in response to VEGF-A, the first new blood vessels formed in vivo were "mother" vessels, greatly enlarged, highly permeable, pericyte-poor sinusoids. Histamine or serotonin, acting on endothelial cells in culture or on tissue sites in vivo, initially reduced expression of thrombspondin-1 (TSP-1), a potent angiogenesis inhibitor
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, thus favoring angiogenesis. Subsequently, however, histamine and serotonin, unlike VEGF-A, upregulated the TSP-1 promoter and restored TSP-1 levels to normal. This triggered a negative feedback loop that caused vascular regression and thus imposed a temporal limit on the angiogenic response induced by histamine and serotonin. An antibody prepared in chickens against mouse thrombospondin-1 was used for immunoblots, as described previously 27 .
Materials and Methods

Materials
Cell culture and assays: Human umbilical vein endothelial cells (HUVEC, Lonza Inc. Walkersville, MD)
were cultured and transduced with retroviruses carrying various genes as previously described 28 . At 80%
confluence, HUVEC were incubated in 0.1% fetal bovine serum (FBS)-containing EBM medium for 24 h and then treated, in all assays described below, with VEGF-A 165 (10 ng/ml), histamine (10 μM), or serotonin (1 μM)
as previously described 28 . In all of the in vitro assays that follow, receptor antagonists (40 μg/ml H1 antagonist, 10 μM H2 antagonist, 3 μM H4 antagonist, 0.25 μM serotonin (5HT) receptor 1,6,7 antagonist, 10 μg/ml serotonin (5HT) receptor 2 antagonist, and 3 μg/ml serotonin (5HT) receptor 3 antagonist) were added 10 min before addition of VEGF-A 165 , histamine or serotonin, whereas 3TSR (50 nM) was added 30 min before. . An adeno-associated virus (AAV1) expressing 3TSR was generated to test the effects of TSP-1 on histamine-and serotonin-induced angiogenesis 32 . with the Student t test, as indicated, using inStat software.
Angiogenesis induced with histamine-and serotonin-releasing pellets:
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Results
Histamine and serotonin induce HUVEC proliferation, migration and tube formation in vitro
We used several different assays to assess the ability of histamine and serotonin to modify the behavior of cultured endothelial cells (EC). As shown in Fig. 1 , both amines significantly stimulated HUVEC incorporation of 3 H thymidine, a measure of cell proliferation (Fig. 1A, a, b) ; HUVEC migration in transwell chambers (Fig.   1B, a, b) ; HUVEC migration in the scratch monolayer wound healing assay (Fig. 1C, a, b, Supplemental Fig.   1S . A); and HUVEC tube formation on Matrigel (Fig. 1D, a, b, Supplemental Fig. 1S, B) . In all of these assays, histamine and serotonin performed about as well as VEGF-A 165 (Fig. 1A-D, c) . SU1489, a selective inhibitor of VEGFR-2, did not inhibit the activities of either histamine or serotonin in any of these assays, though it potently inhibited the activity of VEGF-A 165 (Fig. 1A-D, c) . On the other hand, selective inhibitors of the various histamine and serotonin receptors effectively inhibited histamine and serotonin functions in each of these assays, though different receptor inhibitors were active in different assays ( Fig. 1 , Table 1 ).
Histamine-and serotonin-slow release pellets induce angiogenesis in vivo
Biodegradable, slow release pellets containing varying amounts of histamine or serotonin were implanted in the subcutaneous space of Nu/Nu mice where they induced angiogenesis in a dose-dependent manner ( Fig. 2A, B) .
New blood vessel formation was apparent as early as 3 days, whereas control pellets induced no significant angiogenesis. Based on these preliminary experiments, we chose pellets containing 10 μg histamine and 1μg serotonin for further study. These pellets are reported to release histamine and serotonin continuously and at constant rates (i.e., 20 and 2 ng/hour, respectively) for a period of 21 days and therefore are expected to achieve tissue concentrations of these amines that are well within the pathophysiological range 33, 34 . H1 and H2
antagonists, but not the H4 antagonist, greatly inhibited histamine pellet-induced angiogenesis (Fig. 2C, a-d) .
Antagonists of the 5-HT2 and 5-HT3 serotonin receptors inhibited serotonin-induced angiogenesis, whereas an antagonist of the 5-HT1, 6, and 7 serotonin receptors, had no effect (Fig. 2C, f-i) . Again, the VEGFR-2 kinase inhibitor SU1498, which potently inhibits VEGF-A 165 -induced angiogenesis and microvascular hyperpermeability 24, 35 , had no effect on histamine-or serotonin-induced angiogenesis and microvessel permeability (Fig. 2C, e and j) . Together these data demonstrate that histamine and serotonin induce angiogenesis directly through their specific receptors.
Histamine-and serotonin-induced angiogenesis is dependent on TR3/Nur77
We recently reported that the orphan nuclear receptor TR3 (mouse analogue Nur77) is required for the vascular permeabilizing activities of VEGF-A, histamine, and serotonin 25 , in addition to its requirement for VEGF-Ainduced HUVEC proliferation, tube formation and angiogenesis in Matrigel 24 . We therefore considered the possibility that histamine and serotonin might also require TR3/Nur77 for their angiogenic activities. Initially we took an antisense approach. We showed that transduction of HUVEC with TR3 antisense cDNA reduced TR3 expression by >90%, whereas transduction with LacZ had no effect on TR3 expression 24 . Further, TR3
antisense DNA almost completely inhibited VEGF-A 165 -stimulated HUVEC proliferation in vitro and Matrigel angiogenesis in vivo, whereas transduction with Lac Z had no effect 24 . We have now extended these findings to histamine-and serotonin-induced stimulation of cultured EC. HUVEC transduced with TR3 antisense cDNA exhibited greatly reduced incorporation of 3 H thymidine, migration in transwell chambers and in scratch wound healing assays, and tube formation in response to VEGF-A 165 , histamine or serotonin (Fig. 3A-D , Supplemental   Fig. 2S, A, B) . In addition, almost no angiogenesis developed when histamine or serotonin pellets were implanted in Nur77-/-mice (Fig. 3E) . form first and over time evolve into several types of "daughter" vessels which persist for many months 22 .
The histology of the angiogenic response induced by histamine and serotonin pellets in both nude and wild-type C57Bl/6 mice was at first very similar to that induced by Ad-VEGF-A 164 22 . Large numbers of MV formed initially, reaching a maximum at ~10 days (Fig. 4B, a, b, d, e) . Thereafter, however, as predicted by the macroscopic appearance (Fig. 4A) , MV regressed and only small numbers of slightly enlarged capillaries remained at 15 and 21 days (Fig. 4B, c, f) . Vascular density counts quantified these findings (Fig. 4C ).
To be certain that the regression of angiogenesis after day 10 was not attributable to a failure of histamine or serotonin content or release, we recovered pellets from mice at 14 and 21 days after implantation and suspended them in 100 μl HBSS overnight to extract histamine or serotonin. Similar pellets that had not been implanted were extracted in the same way and served as positive controls. We then tested these extracts for activity in the Miles vascular permeability assay. We found that substantial histamine and serotonin remained in the pellets and were readily extracted at both 14 and 21 days after implantation (Supplemental Fig.   3S ).
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Histamine and serotonin affect TSP-1 expression
Unlike the angiogenic response induced by Ad-VEGF-A 164 , that induced by histamine-and serotonin-releasing pellets was transitory (Fig. 4) , despite continuing release of histamine and serotonin (Supplemental Fig. 3S ).
Since angiogenesis is controlled by a balance of pro-and anti-angiogenic factors, we considered the possibility that histamine and serotonin might also affect the activity of an angiogenic inhibitor, such as TSP-1. Testing this possibility, we found that both histamine and serotonin induced a biphasic response in TSP-1 expression in HUVEC. Initially (1-12h), histamine and serotonin induced a profound reduction in TSP-1 expression, but, at later times, TSP-1 levels returned to near normal levels (Fig. 5A,C) . VEGF-A 165 also downregulated TSP-1 expression, but with slower kinetics; also, TSP-1 levels did not return to normal but remained at reduced plateau levels (Fig. 5A,C) .
We also measured levels of TSP-1 in tissue extracts harvested from sites immediately adjacent to histamine and serotonin pellet implants, and, for comparison, extracts prepared from skin sites of Ad-VEGF-A 164 injection (Fig. 5B,C) . TSP-1 protein levels fell by 88-93% and by 70-98% at histamine and serotonin injections sites, respectively, over the period of 4-10 days when angiogenesis was developing; levels then rebounded in temporal accord with angiogenesis regression (Fig. 4) . In contrast, TSP-1 levels did not change significantly at Ad-VEGF-A 164 injected skin sites over the period of 4-21 days.
3TSR recombinant protein inhibits the histamine-and serotonin-induced responses of cultured HUVEC and angiogenesis in vivo.
The anti-angiogenic activity of TSP-1 is largely mediated by that portion of the molecule referred to as type 1 repeats, and one of us (Lawler) has prepared a recombinant protein, designated 3TSR, that contains all three of the type 1 repeats and that mimics thrombospondin-1's anti-angiogenic action 36 . We therefore tested whether 3TSR could inhibit histamine or serotonin responses on cultured EC. Serum-starved HUVEC were pretreated with 50 nM 3TSR for 30 min and then stimulated with histamine (10 μM) or serotonin (1 μM) to evaluate cell proliferation, migration, and tube formation. 3TSR completely inhibited all of these effects ( We then asked whether the 3TSR recombinant protein could inhibit histamine-or serotonin-induced angiogenesis in vivo. 1 x 10 11 pfu of an adeno-associated virus (AAV) expressing the 3TSR recombinant protein was injected into the flank skin of Nu/Nu mice and the site marked with indelible ink. Two weeks later, histamine or serotonin pellets were implanted subcutaneously immediately beneath AAV-injected sites and tissues were collected 10 days later. As shown in Fig. 6E , histamine-and serotonin-induced angiogenesis was largely inhibited in the AAV-3TSR pretreated mice.
Histamine and serotonin regulate TSP-1 promoter activity, but not directly through TR3.
We next investigated whether histamine or serotonin acted on the TSP-1 promoter. Serum-starved HUVEC were transfected with a TSP-1 promoter-luciferase reporter or control luciferase vector and were then stimulated with histamine, serotonin or VEGF-A
165
. Histamine upregulated TSP-1 promoter activity significantly at 4h, and serotonin did so at both 6 and 16h (Fig. 7A) , timing that correlates well with the return of TSP-1 protein expression at 12-24h (Fig. 5A) . In contrast, VEGF-A 165 had no effect on luciferase expression over the 16 h time course (Fig. 7 A) .
TR3 is a transcription factor. Therefore, we analyzed the transcriptional regulatory elements in the TSP-1 promoter but did not find TR3 conserved regulatory elements 37 . We also tested whether overexpression of TR3 had an effect on TSP-1 expression. Cell extracts from HUVEC that were not transduced, or were transduced with TR3 or with Lac Z cDNAs were subjected to immunoblot analysis with an antibody against TSP-1. TSP-1 expression was not affected by overexpression of TR3 (Fig. 7B , top panel). We had shown previously that TR3 downregulated VE-cadherin expression 25 . Therefore, to demonstrate that the TR3 in our assay was functional, we measured expression of VE-cadherin from the same extracts and found that it was downregulated as expected by overexpression of TR3 (Fig. 7B, middle panel) . Thus, histamine and serotonin regulate TSP-1 promoter activity, but TR3, if involved, acts on TSP-1 by an indirect mechanism.
Discussion
The data presented here provide definitive evidence that histamine and serotonin are potent angiogenic factors at low micromolar concentrations, and that, like VEGF-A 165 , they exert this activity directly through the orphan nuclear receptor and transcription factor TR3/Nur77. Histamine and serotonin both stimulated HUVEC incorporation of 3 H thymidine, migration and tube formation (Figs. 1, A-D) . Further, these responses were inhibited by different selective antagonists of histamine or serotonin receptors, but not by the VEGFR-2 inhibitor SU1498 (Fig. 1 , Table 1 ) and were greatly reduced in HUVEC in which TR3 was knocked down by ~90% (Fig. 3, A-D) . Likewise, histamine and serotonin slow-releasing pellets induced angiogenesis when implanted in nude mice and the responses were inhibited by selective histamine or serotonin receptor antagonists but not by SU1498 (Fig. 2) . Of note, angiogenesis did not develop when pellets were implanted in Nur77 -/-mice (Fig. 3E) . Though the angiogenic responses induced by histamine and serotonin pellets initially mimicked that induced by VEGF-A, they were transitory and began to decline after about 10 days. Investigating the mechanisms responsible, we found that histamine and serotonin downregulated TSP-1 expression for a time in both cultured HUVEC (Fig. 5 A,C) and in vivo in the tissues surrounding implanted pellets (Fig. 5B,C) . The mechanism of TSP-1 downregulation is unknown but could reflect changes in mRNA stability. Subsequent restoration of TSP-1 to normal levels, both in cultured HUVEC and in vivo, was attributable to activation of the TSP-1 promoter by both histamine and serotonin (Fig. 7A) . VEGF-A also downregulated TSP-1 expression in cultured HUVEC, but had little or no effect on TSP-1 expression at skin sites injected with Ad-VEGF-A 164 (Fig.
A-C).
The anti-angiogenic recombinant TSP-1 derived protein, 3TSR, strikingly inhibited both histamine-and serotonin-induced HUVEC proliferation, migration and tube formation (Fig. 6, A-D) . Also, histamine-and serotonin-induced angiogenic responses were strikingly inhibited by local injection of an adeno-associated virus expressing 3TSR (Fig. 6E) . Nonetheless, the relationships between histamine, serotonin, TR3/Nur77 and TSP-1 expression remain elusive. Whereas TR3/Nur77 was found to downregulate VE-cadherin expression and so modulate vascular permeability 25 , overexpression of TR3 had no effect on TSP-1 expression (Fig. 7B) . Further work will be required to elucidate the pathways by which histamine and serotonin regulate TSP-1 expression.
While there is very little data implicating serotonin in angiogenesis since the early report of Zauberman 14 , a number of papers have reported a role for histamine in the angiogenesis associated with acute inflammation. The Norrby group [15] [16] [17] (Fig. 4) .
Ghosh et al 18 also provided evidence that histamine had a role in inflammatory angiogenesis. Using a cotton string implantation model, they found that angiogenesis was greatly reduced in mice null for histidine decarboxylase (HDC), the enzyme responsible for histamine synthesis. They also reported that the H2 blocker cimetidine inhibited angiogenesis in this model; however, in contrast to our work and that of Norrby et al, an H1 receptor inhibitor was without effect. Also, Ghosh et al 18 found that anti-VEGF-A 165 antibodies inhibited the angiogenic response in the string assay. They therefore attributed histamine's angiogenic effect to an accumulation of HDC-expressing macrophages which secreted histamine and so induced VEGF-A 165 formation.
These data are not in conflict with ours in that histamine-and serotonin-secreting pellets elicited very few macrophages (Fig. 4B) . Thus, histamine may induce angiogenesis by two mechanisms, both of which involve
which subsequently upregulates TR3/Nur77 24, 25 .
In addition to their long-studied roles in acute inflammation, histamine and serotonin and their receptors have recently been implicated in cancer 8, 19, 20, [40] [41] [42] [43] . Many reports indicate that both amines are tumor cell mitogens, but in at least some cases they have been implicated in tumor angiogenesis. For example, Natori et al 43 demonstrated that cimetidine, a histamine H2 receptor inhibitor, inhibited the angiogenic response induced by syngeneic CMT93 colon cancer cells. Also, Nocito et al reported decreased angiogenesis and consequent reduced colon cancer growth in serotonin-deficient mice, which they attributed to an induction of the angiogenesis inhibitor angiostatin 8 .
In sum, our data add another layer to the complexity of pathological angiogenesis. Histamine and serotonin, in addition to their many other functions, induce angiogenesis directly by activating the transcription factor TR3/Nur77. After a time, however, histamine and serotonin also inhibit angiogenesis by promoting expression of the angiogenic inhibitor TSP-1. These findings are consistent with the long-held view that histamine and serotonin have roles in acute inflammation and immediate hypersensitivity and suggest that, by truncating angiogenesis, one of their functions may be to prevent these reactions from becoming chronic. On the other hand, to the extent that they also stimulate VEGF-A 165 expression in inflammatory cells 18 , histamine and serotonin may also have roles in promoting the angiogenesis of chronic inflammation.
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The authors declare no competing financial interests. were analyzed with the Kruskal-Wallis test. With regard to the HUVEC data, TSP-1 levels were significantly depressed from 4-8h, but not thereafter, in the case of both histamine and serotonin treatments, whereas TSP-1
24.
was not significantly depressed in response to VEGF until 12h. With regard to the histamine and serotonin in vivo data (B), TSP-1 was significantly reduced over the period of 4-8 days, corresponding to the period of angiogenesis; thereafter, TSP-1 levels rebounded, correlating with angiogenesis regression (Fig. 4) . Ad-VEGF- For
